Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients (vol 50, 1700050, 2017 )

被引：2
|
作者：
Delaunay, Myriam
Cadranel, Jacques
Lusque, Amelie
Meyer, Nicolas
Gounant, Valerie
Moro-Sibilot, Denis
Michot, Jean-Marie
Raimbourg, Judith
Girard, Nicolas
Guisier, Florian
Planchard, David
Metivier, Anne-Cecile
Tomasini, Pascale
Dansin, Eric
Perol, Maurice
Campana, Marion
Gautschi, Oliver
Fruh, Martin
Fumet, Jean-David
Audigier-Valette, Clarisse
Couraud, Sebastien
Dalle, Stephane
Leccia, Marie-Therese
Jaffro, Marion
Collot, Samia
Prevot, Gregoire
Milia, Julie
Mazieres, Julien
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷 / 05期
关键词：
D O I：
10.1183/13993003.50050-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
    Delaunay, Myriam
    Cadranel, Jacques
    Lusque, Amelie
    Meyer, Nicolas
    Gounaut, Valerie
    Moro-Sibilot, Denis
    Michot, Jean-Marie
    Raimbourg, Judith
    Girard, Nicolas
    Guisier, Florian
    Planchard, David
    Metivier, Anne-Cecile
    Tomasini, Pascale
    Dansin, Eric
    Perol, Maurice
    Campana, Marion
    Gautschi, Oliver
    Fruh, Martin
    Fumet, Jean-David
    Audigier-Valette, Clarisse
    Couraud, Sebastien
    Dalle, Stephane
    Leccia, Marie-Therese
    Jaffro, Marion
    Collot, Samia
    Prevot, Gregoire
    Milia, Julie
    Mazieres, Julien
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
  • [2] Interstitial lung disease associated with immune-checkpoint inhibitors in malignant diseases
    Yamagata, A.
    Yokoyama, T.
    Fukuda, Y.
    Ishida, T.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Role of immune-checkpoint inhibitors in lung cancer
    Jain, Prantesh
    Jain, Chhavi
    Velcheti, Vamsidhar
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [4] Interstitial lung disease induced by immune-checkpoint inhibitors correlates with prognosis of advanced non-small cell lung cancer patients
    Sugano, T.
    Seike, M.
    Saito, Y.
    Takano, N.
    Hisakane, K.
    Takahashi, S.
    Tanaka, T.
    Kashiwada, T.
    Nakamichi, S.
    Takeuchi, S.
    Miyanaga, A.
    Minegishi, Y.
    Noro, R.
    Kubota, K.
    Gemma, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 617 - 617
  • [5] Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease
    Suzuki, Kunihiro
    Yanagihara, Toyoshi
    Matsumoto, Koichiro
    Kusaba, Hitoshi
    Yamauchi, Takuji
    Ikematsu, Yuki
    Tanaka, Kentaro
    Otsubo, Kohei
    Inoue, Hiroyuki
    Yoneshima, Yasuto
    Iwama, Eiji
    Arimura-Omori, Masako
    Harada, Eiji
    Hamada, Naoki
    Okamoto, Isamu
    Nakanishi, Yoichi
    INTERNATIONAL IMMUNOLOGY, 2020, 32 (08) : 547 - 557
  • [6] Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer
    Yamagata, Akira
    Yokoyama, Toshihide
    Fukuda, Yasushi
    Ishida, Tadashi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (02) : 251 - 258
  • [7] Economic analyses of immune-checkpoint inhibitors to treat lung cancer
    Vergnenegre, Alain
    Chouaid, Christos
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (03) : 365 - 371
  • [8] Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer
    Akira Yamagata
    Toshihide Yokoyama
    Yasushi Fukuda
    Tadashi Ishida
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 251 - 258
  • [9] Cardiotoxicity in cancer patients treated with immune-checkpoint inhibitors
    Franco, F. F.
    Garitaonaindia, Y.
    Blanco Clemente, M.
    Torrente, M.
    Calvo de Juan, V.
    Collazo Lorduy, A.
    Gutierrez, L.
    Sanchez, J. C.
    del Alba Baamonde, M. A. Gonzalez
    Royuela, A.
    Visedo, G.
    Gonzalez, S. C.
    Martinez Cutillas, M.
    Traseira Puchol, C.
    Aguado, R.
    Mitroi, C. D.
    Provencio, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1406 - S1406
  • [10] Antitumor effects are augmented in mouse models of interstitial-lung disease caused by immune-checkpoint inhibitors
    Arita, Masashi
    Watanabe, Satoshi
    Yanagimura, Naohiro
    Mishina, Yuko
    Sato, Miyuki
    Shoji, Satoshi
    Ichikawa, Kosuke
    Kondo, Rie
    Tanaka, Junta
    Sakagami, Takuro
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    CANCER RESEARCH, 2018, 78 (13)
12345